TERMS AND CONDITIONS OF AWARD FOR LARGE SCALE UNSOLICITED RESEARCHPROJECT APPLICATIONS FOR CLINICAL TRIALS, PREVENTION AND CONTROL

INTERVENTIONS, AND EPIDEMIOLOGICAL STUDIES



NIH GUIDE, Volume 22, Number 45, December 17, 1993



P.T. 34



Keywords:

  Grants Administration/Policy+ 

  Clinical Trial 

  Epidemiology 

  Disease Prevention+ 

  Disease Control+ 



National Cancer Institute



The National Cancer Institute (NCI) would like to clarify the

above-titled Notice published in the NIH Guide, Vol. 22, No. 43,

November 26, 1993, as follows:



The first sentence of the first paragraph is modified as follows:



The National Cancer Institute (NCI) announces that any new or

competing continuation R01 investigator-initiated clinical trial,

prevention or control intervention, or epidemiological study in which

direct costs exceed $500,000 in any year (at a single institution or

in the aggregate for a study proposing multi-institutional

collaborative arrangements submitted as either subcontracts to a

single application or as separate applications) will usually be

awarded only as a cooperative agreement (U01).



The remainder of the published Notice stating the policy is

unchanged.  Program project (P01) grant applications are thus

excluded from the policy and will continue to be accepted by the NCI

according to current guidelines.



.

Return to 1993 Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER) 		  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892 		  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) 		  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.